[1]杜忠斌,武春梅,李润,等.凝聚胺法放射免疫快速测定癌胚抗原的应用[J].国际放射医学核医学杂志,2006,30(5):296-297.
 DU Zhong-bin,WU Chun-mei,LI Run,et al.Application of polybrene in rapid radioimmunoassay carcinoembryonic antigen[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):296-297.
点击复制

凝聚胺法放射免疫快速测定癌胚抗原的应用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
30
期数:
2006年第5期
页码:
296-297
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Application of polybrene in rapid radioimmunoassay carcinoembryonic antigen
作者:
杜忠斌 武春梅 李润 闫沙沙 刘俊红
030001 太原, 解放军264医院核医学科
Author(s):
DU Zhong-bin WU Chun-mei LI Run YAN Sha-sha LIU Jun-hong
Department of Nuclear Medinice, The PLA 264 Hospital, Shartxi, Taiyuan 030001, China
关键词:
癌胚抗原放射免疫测定凝聚胺
Keywords:
Carcinoembtyonic antigenRadioimmunoagsayPolybrene
分类号:
R446
摘要:
目的 探讨凝聚胺在放射免疫测定癌胚抗原(CEA)中的应用。方法 26例血清标本分别用凝聚胺法和常规法相比较。结果 凝聚胺法与常规法比较测定结果无显著差异。该方法的检测限为2 μg/L,线性范围0-80 μg/L,变异系数3.78%,回收率在96.65%-101.31%之间。结论 凝聚胺法简单、快速,可以用于临床常规检测。
Abstract:
Objective Explore the value of polybrene in carcinoembry, onic antigen (CEA) of radioimmunoassay. Methods 26 samples of serum were detection by polyrene and compared with normal test. Results There was not differences between the normal test and ploybrene test. The sensitivity of the assay was 2 μg/L.The linear range was from 0 to 80 μg/L The precision was 3.78 μg/L. The analytical recovery rate was from 96.65% to 101.31%. Conclusion The ploybrene test is simple, rapid and it can be used for normal test in clinic.

参考文献/References:

1 Hammarstrom S,Shively JE,Paxten RJ,et al.Antigenic sites in carcinoembryonic antigen.Cancer Res,1989,49(17):4852-4858.
2 郝立强,万勇.CEA检测及临床应用的新进展.国外医学外科学分册,1999,26(4):197-199.
3 杜忠斌,李林青,邹广凯.凝聚胺在快速测定肥达试验中的应用.中华检验医学杂志,2003,26(6):384-388.

相似文献/References:

[1]惠金子,赵德善.Tg、TgAb及TSH在分化型甲状腺癌术前的预测分析[J].国际放射医学核医学杂志,2015,39(2):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
 Hui Jinzi,Zhao Deshan.The prediction of risk of differentiated thyroid carcinoma with preoperative serum thyroid stimulating hormone, thyrogiobulin and antithyroglobulin antibody[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):110.[doi:10.3760/cma.j.issn.1673-4114.2015.02.002]
[2]陈宁琳,鲍逸民,杨永青.血浆ATⅡ、NPY、IGF-1和hs-CRP水平测定在评估冠心病患者严重程度中的应用价值[J].国际放射医学核医学杂志,2014,38(3):167.[doi:10.3760/cma.j.issn.1673-4114.2014.03.007]
 Chen Ninglin,Bao Yimin,Yang Yongqing.The application value of plsama ATⅡ, NPY, IGF-1 and hs-CRP levels in evaluation of coronary heart disease severity[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):167.[doi:10.3760/cma.j.issn.1673-4114.2014.03.007]
[3]郑青,鲍逸民,杨永青.慢性心力衰竭患者血脂、血浆NT-ProBNP、CTnⅠ和hs-CRP水平测定的临床分析[J].国际放射医学核医学杂志,2014,38(4):232.[doi:10.3760/cma.j.issn.1673-4114.2014.04.006]
 Zheng Qing,Bao Yimin,Yang Yongqing.The clinical analysis of blood lipid and plasma NT-proBNP, CTnⅠ and hs-CRP levels determined in patients with chronic heart failure[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):232.[doi:10.3760/cma.j.issn.1673-4114.2014.04.006]
[4]赵若愚,鲍逸民,杨永青.血浆心肌细胞损伤标志物检测急性心肌梗死患者心肌损伤的临床研究[J].国际放射医学核医学杂志,2014,38(4):235.[doi:10.3760/cma.j.issn.1673-4114.2014.04.007]
 Zhao Ruoyu,Bao Yimin,Yang Yongqing.The clinical study of plasma myocardial cell damage markers in detecting myocardial injury patients with acute myocardial infraction[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):235.[doi:10.3760/cma.j.issn.1673-4114.2014.04.007]
[5]朱同华,杨鸿林,钮丽萍.血浆CYFRA21-1和CA125、CA199、CA153联合检测对肺癌的辅助诊断价值[J].国际放射医学核医学杂志,2014,38(5):304.[doi:10.3760/cma.j.issn.1673-4114.2014.05.007]
 Zhu Tong-hua,Yang Hong-lin,Niu Li-ping.The value of combined detection of plasma CYFRA21-1 and CA125, CA199, CA153 in the accessory diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):304.[doi:10.3760/cma.j.issn.1673-4114.2014.05.007]
[6]黄春玲,查金顺,蒋婷吟.甲状腺功能亢进症患者血浆中TNF-α1和IL-2水平的临床分析[J].国际放射医学核医学杂志,2012,36(2):92.[doi:10.3760/cma.j.issn.1673-4114.2012.02.008]
 HUANG Chunling,ZHA Jin-shun,JIANG Ting-yin.The clinical analysis of the TNF-α1 and IL-2 levels in patients with hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):92.[doi:10.3760/cma.j.issn.1673-4114.2012.02.008]
[7]陈晓毓,李希圣,林夏鸿,等.肥胖患者脂联素基因第45位点单核苷酸多态性与血浆脂联素水平及胰岛素抵抗的相关性研究[J].国际放射医学核医学杂志,2012,36(5):269.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.003]
 CHEN Xiao-yu,LI Xi-sheng,LIN Xia-hong,et al.Association of single nucleotide polymorphism at position 45 in adiponectin gene with plasma adiponectin level and insulin resistance in obesity[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):269.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.003]
[8]孙启和,孙彬,杨永青.冠心病患者血清细胞因子和超敏C-反应蛋白水平测定的临床意义[J].国际放射医学核医学杂志,2010,34(5):291.[doi:10.3760/cma.j.issn.1673-4114.2010.05.010]
 SUN Qi-he,SUN Bin,YANG Yong-qing.Clinical application of changes of serum cytokines and hypersensitive C-reactive protein in patients with coronary heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):291.[doi:10.3760/cma.j.issn.1673-4114.2010.05.010]
[9]陆永怡,陈群,杨永青.原发性高血压PRA、AngⅡ分型和IGF-1水平的测定[J].国际放射医学核医学杂志,2010,34(5):294.[doi:10.3760/cma.j.issn.1673-4114.2010.05.011]
 LU Yong-yi,CHEN Qun,YANG Yong-qing.Application of determination of PRA, Ang Ⅱ and IGF-1 levels in the study of typing of essential hypertension[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):294.[doi:10.3760/cma.j.issn.1673-4114.2010.05.011]
[10]路宝士,高玉芳.血清CA15-3、CEA检测联合全身骨显像在乳腺癌骨转移中的诊断价值[J].国际放射医学核医学杂志,2011,35(2):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
 LU Bao-shi,GAO Yu-fang.The value of combined examination of serum CA15-3, CEA level and whole body bone scan in the diagnosis of bone metastasis in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):107.[doi:10.3760/cma.j.issn.1673-4114.2011.02.010]
[11]胡红永,汤建林,李玉莹,等.肿瘤标志物CEA、CA19-9、CA242联检在结直肠癌患者诊断中的应用[J].国际放射医学核医学杂志,2010,34(2):97.[doi:10.3760/cma.j.issn.1673-4114.2010.02.009]
 HU Hong-yong,TANG Jian-lin,LI Yu-ying,et al.The value of combined tumor markers of CEA, CA19-9 and CA242 for diagnosis of patients with colorectal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):97.[doi:10.3760/cma.j.issn.1673-4114.2010.02.009]

备注/Memo

备注/Memo:
收稿日期:2005-04-28。
通讯作者:杜忠斌,E-mail:wjc771124@126.com
更新日期/Last Update: 1900-01-01